MAPK pathway inhibition induces MET and GAB1 levels, priming BRAF mutant melanoma for rescue by hepatocyte growth factor
Sean Caenepeel(Amgen (United States)), Paul E. Hughes(Amgen (United States))
Cited by 46
Related Papers
Integrin activation controls metastasis in human breast cancer
|Proceedings of the National Academy of Sciences|2001|580